These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 24793669

  • 1. Effect of one-cycle remote ischemic preconditioning to reduce myocardial injury during percutaneous coronary intervention.
    Zografos TA, Katritsis GD, Tsiafoutis I, Bourboulis N, Katsivas A, Katritsis DG.
    Am J Cardiol; 2014 Jun 15; 113(12):2013-7. PubMed ID: 24793669
    [Abstract] [Full Text] [Related]

  • 2. Remote ischemic preconditioning improves outcome at 6 years after elective percutaneous coronary intervention: the CRISP stent trial long-term follow-up.
    Davies WR, Brown AJ, Watson W, McCormick LM, West NE, Dutka DP, Hoole SP.
    Circ Cardiovasc Interv; 2013 Jun 15; 6(3):246-51. PubMed ID: 23696599
    [Abstract] [Full Text] [Related]

  • 3. Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: a prospective, randomized control trial.
    Hoole SP, Heck PM, Sharples L, Khan SN, Duehmke R, Densem CG, Clarke SC, Shapiro LM, Schofield PM, O'Sullivan M, Dutka DP.
    Circulation; 2009 Feb 17; 119(6):820-7. PubMed ID: 19188504
    [Abstract] [Full Text] [Related]

  • 4. Effect of remote ischemic preconditioning on serum troponin T level following elective percutaneous coronary intervention.
    Ahmed RM, Mohamed el-HA, Ashraf M, Maithili S, Nabil F, Rami R, Mohamed TI.
    Catheter Cardiovasc Interv; 2013 Nov 01; 82(5):E647-53. PubMed ID: 23404916
    [Abstract] [Full Text] [Related]

  • 5. Remote ischemic preconditioning reduces myocardial injury in patients undergoing coronary stent implantation.
    Luo SJ, Zhou YJ, Shi DM, Ge HL, Wang JL, Liu RF.
    Can J Cardiol; 2013 Sep 01; 29(9):1084-9. PubMed ID: 23414904
    [Abstract] [Full Text] [Related]

  • 6. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
    Prasad A, Gössl M, Hoyt J, Lennon RJ, Polk L, Simari R, Holmes DR, Rihal CS, Lerman A.
    Catheter Cardiovasc Interv; 2013 May 01; 81(6):930-6. PubMed ID: 22517646
    [Abstract] [Full Text] [Related]

  • 7. Rosuvastatin pretreatment in patients undergoing elective PCI to reduce the incidence of myocardial periprocedural necrosis: the ROMA trial.
    Sardella G, Conti G, Donahue M, Mancone M, Canali E, De Carlo C, Di Roma A, Calcagno S, Lucisano L, Fedele F.
    Catheter Cardiovasc Interv; 2013 Jan 01; 81(1):E36-43. PubMed ID: 22517610
    [Abstract] [Full Text] [Related]

  • 8. Impact of plaque composition on cardiac troponin elevation after percutaneous coronary intervention: an ultrasound analysis.
    Hong YJ, Mintz GS, Kim SW, Lee SY, Okabe T, Pichard AD, Satler LF, Waksman R, Kent KM, Suddath WO, Weissman NJ.
    JACC Cardiovasc Imaging; 2009 Apr 01; 2(4):458-68. PubMed ID: 19580729
    [Abstract] [Full Text] [Related]

  • 9. Effects of remote ischemic preconditioning on myocardial injury and endothelial function and prognosis after percutaneous coronary intervention in patients with acute coronary syndrome.
    Zhou FZ, Song W, Yin LH, Song ZF, Yang S, Yang FB, Liu JF, Song YG, Zhang HY, Zhang ZM.
    Eur Rev Med Pharmacol Sci; 2017 Oct 01; 21(20):4642-4648. PubMed ID: 29131250
    [Abstract] [Full Text] [Related]

  • 10. Remote ischemic postconditioning during percutaneous coronary interventions: remote ischemic postconditioning-percutaneous coronary intervention randomized trial.
    Lavi S, D'Alfonso S, Diamantouros P, Camuglia A, Garg P, Teefy P, Jablonsky G, Sridhar K, Lavi R.
    Circ Cardiovasc Interv; 2014 Apr 01; 7(2):225-32. PubMed ID: 24692535
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of electroacupuncture pretreatment for myocardial injury in patients undergoing percutaneous coronary intervention: A randomized clinical trial with a 2-year follow-up.
    Wang Q, Liang D, Wang F, Li W, Han Y, Zhang W, Xie Y, Xin W, Zhou B, Sun D, Cao F, Xiong L.
    Int J Cardiol; 2015 Sep 01; 194():28-35. PubMed ID: 26011261
    [Abstract] [Full Text] [Related]

  • 12. Impact of long-term statin therapy on postprocedural myocardial infarction in patients undergoing nonemergency percutaneous coronary intervention.
    Gordin J, Haider A, Swaminathan RV, Kim LK, Minutello RM, Bergman G, Wong SC, Feldman DN.
    Am J Cardiol; 2012 Nov 15; 110(10):1397-404. PubMed ID: 22858186
    [Abstract] [Full Text] [Related]

  • 13. Remote ischaemic postconditioning: does it protect against ischaemic damage in percutaneous coronary revascularisation? Randomised placebo-controlled clinical trial.
    Carrasco-Chinchilla F, Muñoz-García AJ, Domínguez-Franco A, Millán-Vázquez G, Guerrero-Molina A, Ortiz-García C, Enguix-Armada A, Alonso-Briales JH, Hernández-García JM, de Teresa-Galván E, Jiménez-Navarro MF.
    Heart; 2013 Oct 15; 99(19):1431-7. PubMed ID: 23850844
    [Abstract] [Full Text] [Related]

  • 14. Multimodality Intravascular Imaging to Predict Periprocedural Myocardial Infarction During Percutaneous Coronary Intervention.
    Kini AS, Motoyama S, Vengrenyuk Y, Feig JE, Pena J, Baber U, Bhat AM, Moreno P, Kovacic JC, Narula J, Sharma SK.
    JACC Cardiovasc Interv; 2015 Jun 15; 8(7):937-45. PubMed ID: 26088511
    [Abstract] [Full Text] [Related]

  • 15. Remote ischemic preconditioning stimulus does not reduce microvascular resistance or improve myocardial blood flow in patients undergoing elective percutaneous coronary intervention.
    Hoole SP, Heck PM, White PA, Khan SN, O'Sullivan M, Clarke SC, Dutka DP.
    Angiology; 2009 Jun 15; 60(4):403-11. PubMed ID: 19106155
    [Abstract] [Full Text] [Related]

  • 16. Remote ischemic postconditioning: does it protect against ischemic damage in percutaneous coronary revascularization? justification and design of a randomized placebo-controlled clinical trial.
    Jiménez-Navarro MF, Carrasco-Chinchilla F, Muñoz-García AJ, Domínguez-Franco A, Caballero-Borrego J, Alonso-Briales JH, Hernández-García JM, de Teresa-Galván E.
    Cardiology; 2011 Jun 15; 119(3):164-9. PubMed ID: 21952349
    [Abstract] [Full Text] [Related]

  • 17. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX, Li XL, Zhang MZ, Wang XW, Guo YL, Zhu CG, Ren Y, Li S, Zhang Y, Liu G, Xu RX, Dong Q, Li JJ.
    Scand J Clin Lab Invest; 2015 Nov 15; 75(7):568-77. PubMed ID: 26203960
    [Abstract] [Full Text] [Related]

  • 18. Cardioprotective role of remote ischemic periconditioning in primary percutaneous coronary intervention: enhancement by opioid action.
    Rentoukas I, Giannopoulos G, Kaoukis A, Kossyvakis C, Raisakis K, Driva M, Panagopoulou V, Tsarouchas K, Vavetsi S, Pyrgakis V, Deftereos S.
    JACC Cardiovasc Interv; 2010 Jan 15; 3(1):49-55. PubMed ID: 20129568
    [Abstract] [Full Text] [Related]

  • 19. Long-term outcome following remote ischemic postconditioning during percutaneous coronary interventions-the RIP-PCI trial long-term follow-up.
    Lavi S, Abu-Romeh N, Wall S, Alemayehu M, Lavi R.
    Clin Cardiol; 2017 May 15; 40(5):268-274. PubMed ID: 28075499
    [Abstract] [Full Text] [Related]

  • 20. Cardiac remote ischaemic preconditioning reduces periprocedural myocardial infarction for patients undergoing percutaneous coronary interventions: a meta-analysis of randomised clinical trials.
    D'Ascenzo F, Moretti C, Omedè P, Cerrato E, Cavallero E, Er F, Presutti DG, Colombo F, Crimi G, Conrotto F, Dinicolantonio JJ, Chen S, Prasad A, Biondi Zoccai G, Gaita F.
    EuroIntervention; 2014 May 15; 9(12):1463-71. PubMed ID: 24755386
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.